SHR0410 Injection + SHR0410 Injection + Placebo
Phase 3UNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 36/100
36
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Postoperative Pain Of Laparoscopic Surgery
Conditions
Postoperative Pain Of Laparoscopic Surgery
Trial Timeline
Jul 1, 2022 → Feb 28, 2023
NCT ID
NCT05459220About SHR0410 Injection + SHR0410 Injection + Placebo
SHR0410 Injection + SHR0410 Injection + Placebo is a phase 3 stage product being developed by Jiangsu Hengrui Medicine for Postoperative Pain Of Laparoscopic Surgery. The current trial status is unknown. This product is registered under clinical trial identifier NCT05459220. Target conditions include Postoperative Pain Of Laparoscopic Surgery.
What happened to similar drugs?
10 of 20 similar drugs in Postoperative Pain Of Laparoscopic Surgery were approved
Approved (10) Terminated (2) Active (9)
Hype Score Breakdown
Clinical
17
Activity
4
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05459220 | Phase 3 | UNKNOWN |
Competing Products
20 competing products in Postoperative Pain Of Laparoscopic Surgery